IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 13,827

Sort by:

Bowel Obstruction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bowel obstruction markets reached a value of US$ 16.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 27.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 136 pages

Bradykinesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bradykinesia markets are expected to exhibit a CAGR of 7.73% during 2024-2034. The bradykinesia market has been comprehensively analyzed in IMARC's new report titled 'Bradykinesia Market:...

May 2024 139 pages

Brain Hemorrhage Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major brain hemorrhage markets reached a value of US$ 136.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 211.0 Million by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 138 pages

Breast Cancer Lymphedema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major breast cancer lymphedema markets are expected to exhibit a CAGR of 9.03% during 2024-2034. The breast cancer lymphedema market has been comprehensively analyzed in IMARC's new report title...

May 2024 140 pages

Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major breast cancer markets are expected to exhibit a CAGR of 5.58% during 2024-2034. The breast cancer market has been comprehensively analyzed in IMARC's new report titled 'Breast Cancer Marke...

May 2024 130 pages

Bronchial Hyperreactivity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bronchial hyperreactivity markets reached a value of US$ 13.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 22.6 Billion by 2034, exhibiting a growth rate (CAG...

May 2024 131 pages

Bronchiectasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bronchiectasis markets reached a value of US$ 438.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 731.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.7...

May 2024 138 pages

Bronchiolitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bronchiolitis markets are expected to exhibit a CAGR of 3.5% during 2024-2034. The bronchiolitis market has been comprehensively analyzed in IMARC's new report titled 'Bronchiolitis Market...

May 2024 138 pages

Bronchiolitis Obliterans Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bronchiolitis obliterans syndrome markets reached a value of US$ 60.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 94.0 Million by 2034, exhibiting a growth r...

May 2024 134 pages

Bronchitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bronchitis markets reached a value of US$ 4.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2.42% durin...

May 2024 135 pages

Bronchopulmonary Dysplasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bronchopulmonary dysplasia markets reached a value of US$ 269.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 445.6 Million by 2034, exhibiting a growth rate (...

May 2024 130 pages

Bulimia Nervosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bulimia nervosa markets reached a value of US$ 369.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 606.1 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 133 pages

Bullous Pemphigoid Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bullous pemphigoid markets reached a value of US$ 245.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,379.3 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 128 pages

Bunion Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bunion markets reached a value of US$ 539.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 943.7 Million by 2034, exhibiting a growth rate (CAGR) of 5.22% durin...

May 2024 130 pages

Burkitt Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Burkitt lymphoma markets reached a value of US$ 996.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,627.8 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 139 pages

Burn Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major burn pain markets are expected to exhibit a CAGR of 5.64% during 2024-2034. The burn pain market has been comprehensively analyzed in IMARC's new report titled 'Burn Pain Market: Epidemiol...

May 2024 131 pages

Calciphylaxis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major calciphylaxis markets reached a value of US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.6 Billion by 2034, exhibiting a growth rate (CAGR) of 7.37% du...

May 2024 134 pages

Cancer Anorexia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cancer anorexia markets are expected to exhibit a CAGR of 10.48% during 2024-2034. The cancer anorexia market has been comprehensively analyzed in IMARC's new report titled 'Cancer Anorexi...

May 2024 138 pages

Cancer Cachexia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cancer cachexia markets are expected to exhibit a CAGR of 3.77% during 2024-2034. The cancer cachexia market has been comprehensively analyzed in IMARC's new report titled 'Cancer Cachexia...

May 2024 134 pages

Cancer Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cancer pain markets reached a value of US$ 1,717.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,523.4 Million by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 134 pages

Candidemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major candidemia markets are expected to exhibit a CAGR of 3.16% during 2024-2034. The candidemia market has been comprehensively analyzed in IMARC's new report titled 'Candidemia Market: Epidem...

May 2024 129 pages

Cardiac Arrhythmias Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cardiac arrhythmias markets reached a value of US$ 4.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 138 pages

Cardiomyopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cardiomyopathy markets are expected to exhibit a CAGR of 6.07% during 2024-2034. The cardiomyopathy market has been comprehensively analyzed in IMARC's new report titled 'Cardiomyopathy Ma...

May 2024 134 pages

Cardiorenal Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cardiorenal syndrome markets reached a value of US$ 29.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 91.2 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 134 pages

Cardiotoxicity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cardiotoxicity markets are expected to exhibit a CAGR of 6.22% during 2024-2034. The cardiotoxicity market has been comprehensively analyzed in IMARC's new report titled 'Cardiotoxicity Ma...

May 2024 137 pages

Cardiovascular Calcification Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cardiovascular calcification markets reached a value of US$ 119.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 190.6 Billion by 2034, exhibiting a growth rate...

May 2024 129 pages

Carotid Artery Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major carotid artery disease markets are expected to exhibit a CAGR of 3.03% during 2024-2034. The carotid artery disease market has been comprehensively analyzed in IMARC's new report titled 'C...

May 2024 128 pages

Carpal Tunnel Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major carpal tunnel syndrome markets reached a value of US$ 427.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 637.8 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 138 pages

Cartilage Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cartilage diseases markets reached a value of US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 11....

May 2024 134 pages

Catheter-Related Bloodstream Infections (CRBSIs) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major catheter-related bloodstream infections (CRBSIs) markets reached a value of US$ 988.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1508.8 Million by 2034, exh...

May 2024 128 pages

Celiac Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Celiac disease markets reached a value of US$ 584.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,362.1 Million by 2034, exhibiting a growth rate (CAGR) of 7...

May 2024 132 pages

Central Pain Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major central pain syndrome markets reached a value of US$ 5.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.0 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 129 pages

Cerebral Aneurysm Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cerebral aneurysm markets are expected to exhibit a CAGR of 7.06% during 2024-2034. The cerebral aneurysm market has been comprehensively analyzed in IMARC's new report titled 'Cerebral An...

May 2024 139 pages

Cerebral Palsy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cerebral palsy markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.5 Billion by 2034, exhibiting a growth rate (CAGR) of 2.53% d...

May 2024 128 pages

Cervical Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cervical cancer markets reached a value of US$ 405.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 583.4 Million by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 137 pages

Cervical Dysplasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cervical dysplasia markets are expected to exhibit a CAGR of 3.2% during 2024-2034. The cervical dysplasia market has been comprehensively analyzed in IMARC's new report titled 'Cervical D...

May 2024 138 pages

Cervical Dystonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cervical dystonia markets reached a value of US$ 148.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 270.0 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 138 pages

Cervix Lesion Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cervix lesion markets are expected to exhibit a CAGR of 3.92% during 2024-2034. The cervix lesion market has been comprehensively analyzed in IMARC's new report titled 'Cervix Lesion Marke...

May 2024 128 pages

Chagas Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Chagas disease markets are expected to exhibit a CAGR of 3.19% during 2024-2034. The Chagas disease market has been comprehensively analyzed in IMARC's new report titled 'Chagas Disease Ma...

May 2024 135 pages

Charcot-Marie-Tooth Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Charcot-Marie-Tooth disease markets reached a value of US$ 814.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8,995.2 Million by 2034, exhibiting a growth rat...

May 2024 139 pages

Chemotherapy-Induced Anemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major chemotherapy-induced anemia markets are expected to exhibit a CAGR of 7.2% during 2024-2034. The chemotherapy-induced anemia market has been comprehensively analyzed in IMARC's new report...

May 2024 137 pages

Chemotherapy-Induced Diarrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chemotherapy-induced diarrhea markets reached a value of US$ 84.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 153.1 Million by 2034, exhibiting a growth rate...

May 2024 130 pages

Chemotherapy-Induced Hearing Loss Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chemotherapy-induced hearing loss markets reached a value of US$ 9.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13.3 Million by 2034, exhibiting a growth ra...

May 2024 136 pages

Chemotherapy-Induced Neutropenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chemotherapy-induced neutropenia markets reached a value of US$ 371.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 455.7 Million by 2034, exhibiting a growth...

May 2024 138 pages

Chemotherapy Induced Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chemotherapy induced pain markets are expected to exhibit a CAGR of 4.15% during 2024-2034 The chemotherapy induced pain market has been comprehensively analyzed in IMARC's new report titl...

May 2024 128 pages

Chemotherapy-Induced Peripheral Neuropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chemotherapy-induced peripheral neuropathy markets are expected to exhibit a CAGR of 4.44% during 2024-2034. The chemotherapy-induced peripheral neuropathy market has been comprehensively...

May 2024 129 pages

Chiari Malformation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Chiari malformation markets are expected to exhibit a CAGR of 6.43% during 2024-2034. The Chiari malformation market has been comprehensively analyzed in IMARC's new report titled 'Chiari...

May 2024 134 pages

Chickenpox Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chickenpox markets are expected to exhibit a CAGR of 3.9% during 2024-2034. The chickenpox market has been comprehensively analyzed in IMARC's new report titled 'Chickenpox Market: Epidemi...

May 2024 128 pages

Choroideremia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major choroideremia markets are expected to exhibit a CAGR of 4.22% during 2024-2034. The choroideremia market has been comprehensively analyzed in IMARC's new report titled 'Choroideremia Marke...

May 2024 133 pages

Chronic Bronchitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic bronchitis markets are expected to exhibit a CAGR of 2.69% during 2024-2034. The chronic bronchitis market has been comprehensively analyzed in IMARC's new report titled 'Chronic B...

May 2024 135 pages

Filters

Clear all